Virtu Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtu Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$60K	Buy	+16,960	New	+$69.5K	﹤0.01%	1259
2024 Q4	–	Sell	-18,962	Closed	-$78K	–	1782
2024 Q3	$78K	Buy	+18,962	New	+$102K	﹤0.01%	944
2023 Q2	–	Sell	-11,722	Closed	-$123K	–	1756
2023 Q1	$123K	Buy	+11,722	New	+$131K	0.01%	911
2022 Q3	–	Sell	-10,707	Closed	-$123K	–	1957
2022 Q2	$123K	Buy	+10,707	New	+$126K	0.01%	893
2021 Q1	–	Sell	-17,141	Closed	-$195K	–	1807
2020 Q4	$195K	Buy	+17,141	New	+$188K	0.02%	872
2019 Q4	$147K	Sell	11,067 -5,888	-35%	-$64.9K	0.01%	1011
2019 Q3	$146K	Buy	+16,955	New	+$165K	0.01%	1026

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtu Financial's IRWD Position: Q1 2026 in Review

Virtu Financial opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 16,960 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #1259 among its holdings. This is a return to the name: Virtu Financial previously reported a position in IRWD as recently as Q3 2024.

Virtu Financial first reported a position in IRWD in Q3 2019 and has held it in 7 quarters since. The position peaked at $195K in Q4 2020. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Virtu Financial held 16,960 shares of Ironwood Pharmaceuticals worth $60K as of Q1 2026.
Ironwood Pharmaceuticals was a new Virtu Financial position in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1259 holding.
Virtu Financial first reported a position in Ironwood Pharmaceuticals in Q3 2019 and has held it in 7 quarters since.
Virtu Financial's Ironwood Pharmaceuticals position peaked at $195K in Q4 2020.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.